The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.
about
Treatment for lupus nephritisLupus Nephritis: A Different Disease in European Patients?Lupus Nephritis in Asia: Clinical Features and ManagementCurrent and emerging treatment options in the management of lupusManagement of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesLupus nephritis: the evolving role of novel therapeuticsUnmet medical needs in systemic lupus erythematosusA treatment algorithm for children with lupus nephritis to prevent developing renal failureAn Update on Treatment and Management of Pediatric Systemic Lupus ErythematosusCrossing the Atlantic: the Euro-Lupus Nephritis regimen in North AmericaA proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis TrialTwo cases of refractory thrombocytopenia in systemic lupus erythematosus that responded to intravenous low-dose cyclophosphamide.EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndromeCurrent status of lupus nephritis.Recent clinical trials in lupus nephritis.Is newer safer? Adverse events associated with first-line therapies for ANCA-associated vasculitis and lupus nephritis.Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.Role of early repeated renal biopsies in lupus nephritis.Belimumab for the treatment of systemic lupus erythematosus.Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis.Systemic lupus erythematosus: review of synthetic drugs.Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.Current and novel therapeutics in the treatment of systemic lupus erythematosusRenal involvement in autoimmune connective tissue diseases.Cyclophosphamide-induced posterior reversible encephalopathy syndrome (PRES): a case report.Nonmalignant diseases and treatments associated with primary ovarian failure: an expanded role for fertility preservation.Comparison of alternative primary outcome measures for use in lupus nephritis clinical trialsComparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials.Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.Lupus nephritis: an overview of recent findings.National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia.Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study.Understanding lupus nephritis: diagnosis, management, and treatment options.Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow TransplantationTherapy of lupus nephritis: lessons learned from clinical research and daily care of patients.Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study.American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisCost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus NephritisClinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri LankaJoint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
P2860
Q24202572-DDD56141-A542-499F-B237-AD057F2D135CQ26740483-EF08ABFC-6849-4ADB-84B3-7CC6BA66AF3FQ26740487-43C79945-BCE5-4CA5-AC74-4BE5A6C0BBD3Q26741266-DFEF71BC-B975-452B-B1AB-40C4DF5940C0Q26774815-2C03A868-C990-4912-8195-1A6D0E64E785Q26998390-6B992040-0409-431D-9D1B-376B7FCB745DQ27005906-AFD78B04-F2E7-45E4-A90D-C65791BF6DC2Q27026880-6E9FEB9B-45C6-4ACB-9FE1-5F64D3567BAAQ28074348-AE082A16-B20B-458F-B422-8BBE795BECD1Q28645743-7B4CB768-995E-4056-BF64-4241E4895300Q31029893-6E7634A5-BA85-4F1C-97D3-F0AC469E9349Q33406440-223A266B-ACB0-44D6-93D1-0C2A2CC20AC0Q33731711-4252AF9F-77DF-4F1E-9434-04FC659D4A05Q33882751-4CFCB49F-A0F6-489B-8543-7D4AF196FAC6Q33924437-C6245664-80AE-441A-892A-2784448F4514Q34124711-D5089C10-292E-4368-A539-EEAD86D4F0A7Q34409787-EC7FF5B5-B493-4AE6-AA5B-C93B3BED0D82Q34424633-EE365DB0-8B50-410D-B300-FABE7584E38CQ34455827-22725D10-68F5-487E-9115-A270B1B864F9Q34490782-49113ED5-B076-47AD-A32B-A7DDDCD6F8ACQ34498515-28CF9AC7-3A39-47DE-8AD1-1CB418DD04B5Q34613945-9FAFD9C4-FBAF-4D4C-92AB-467E99415F54Q34648851-4816C97F-8EE7-413F-98E5-F3972E6A15D6Q34654954-AE064CF7-868F-430A-9993-7728E85E7CB9Q34995019-8DBF7C11-B27C-469D-AA66-98380DCD935EQ35267073-2B0FFF91-102C-4685-B3A2-1C3B09BC8807Q35430178-4248E02F-41C3-4F01-BAF3-1FAE8001639EQ35544692-78F03441-583F-45F2-8CC1-0CD41972AC94Q35761089-0E437FC1-686F-4617-A033-C9CDC0FA325DQ35867038-68D6D5FB-587D-460F-883B-41816B8C21A1Q35885259-B02F700C-6569-4426-8EC4-59C943F6198DQ35927877-EEA14A70-F00D-4F0A-BCC4-BFF9E23BB98DQ36008840-2D31854F-565F-421D-9AC9-CC534F4147D5Q36020897-3D5D066B-EF96-4B0F-A24A-EC8861D9692DQ36084894-3A8E9482-E974-4C07-9CF4-158F969655B2Q36157955-1318AE95-8A85-4E1A-B6C2-262591CB1358Q36221407-4F9D2D70-DDBF-4FDB-BF5F-111C0048D2BAQ36265568-F24A3580-2B03-4F80-B79D-90A9B49878FCQ36266807-5CDC0CBE-B6A4-40DA-817A-69CE2E25F64BQ36302245-C974927E-9A31-41ED-842E-9C0B569658E0
P2860
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The 10-year follow-up data of ...... intravenous cyclophosphamide.
@ast
The 10-year follow-up data of ...... intravenous cyclophosphamide.
@en
type
label
The 10-year follow-up data of ...... intravenous cyclophosphamide.
@ast
The 10-year follow-up data of ...... intravenous cyclophosphamide.
@en
prefLabel
The 10-year follow-up data of ...... intravenous cyclophosphamide.
@ast
The 10-year follow-up data of ...... intravenous cyclophosphamide.
@en
P2093
P50
P356
P1476
The 10-year follow-up data of ...... intravenous cyclophosphamide.
@en
P2093
D Abramovicz
D Blockmans
E de Ramon Garrido
F A Houssiau
G D Sebastiani
G Depresseux
H Direskeneli
P356
10.1136/ARD.2008.102533
P407
P577
2010-01-01T00:00:00Z